Virtual QI Workshop Opportunity - Improving HR+/HER2- Metastatic Breast Cancer Patient Care
ACCC is inviting up to 3 cancer programs to participate in a virtual, expert-led quality improvement workshop in Summer 2025 focused on enhancing quality of life for patients with advanced hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer. Participating programs will receive:
Interested programs should email tvanoort@accc-cancer.org by Monday, July 7.
ACCC Welcomes its Newest Members
ACCC Position Statement: Protecting Cancer Research and Patient Care Access
ACCC strongly opposes recent executive actions limiting NIH funding and other federal support for medical research and the House budget resolution that would reduce Medicaid funding. These changes threaten to undermine cancer research infrastructure, reduce patient access to care, and reverse progress in cancer treatment outcomes nationwide. Read the full statement on the ACCC website.
ACCC Offers a New Continuing Education Opportunity
This continuing education opportunity provides guidance on managing HR+, HER2- metastatic breast cancer and is designed for physicians, nurses, pharmacists, physician assistants, and the entire multidisciplinary cancer care team. The course explores first-, second-, and third-line therapies for disease progression, strategies to manage treatment-related toxicities, and approaches to enhance patients’ quality of life.
ACCC Releases 2 New Resource Libraries!
Relapsed/Refractory Mantle Cell Lymphoma Care. Though mantle cell lymphoma (MCL) is incurable in most people, there have been major advancements in treatment options in recent years. Explore the resources ACCC has curated to assist community cancer programs with providing care for patients with relapsed/refractory MCL. Share this comprehensive collection of videos, articles, podcasts, and other tools with your colleagues today to help providers, patients, and caregivers navigate current treatment options.
Bispecific Antibodies. Prepare your cancer program for the successful integration of bispecific antibodies into community oncology practice with this new, comprehensive bank of materials. This resource library provides the multidisciplinary care team with training and resources, consensus recommendations, and information about policies and procedures. Explore evidence-based best practices for managing adverse events, evaluating and mitigating risks, and health literacy support today.
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
